Log in Request a free trial

Request a free trial Log in
Products
Solutions
Data
News & Analysis
About
Blog

News & Analysis

driven by the PitchBook Platform

Venture Capital
Private Equity
M&A
Tech
Europe

reports Subscribe

PE-backed ACH buys Kaopectate

March 26, 2020

Share:

Arcadia Consumer Healthcare has acquired the US rights to digestive medicine Kaopectate from Sanofi. Avista Capital Partners has backed Arcadia Consumer Healthcare (fka Kramer Laboratories) alongside Dana Holdings since 2018.

Share:





Tags:

Private Equity,
M&A

Related content

Products

PitchBook Desktop
PitchBook Mobile
CRM Integration
Excel Plugin
Chrome Extension
Direct Data
Institutional Research Group
Product Releases

Pitchbook for

Private Market Valuations

Profile Previews

Solutions

Private Market Intel
Fundraising
Deal Sourcing
Due Diligence
Business Development
Networking
Deal Execution

Blog

Webinars

Video Library

Data

Companies
Investors
Deals
M&A
Limited Partners
Funds
Financials
Advisors
Professionals
Debt and Lenders
Research Process

News & analysis

Reports
Newsletter
Advertise

About

Customer Success
Client Testimonials
What Sets Us Apart
Press Inquiries
Partnerships
Careers

Follow us







US Headquarters

+1 (206) 623.1986
901 Fifth Avenue
Suite 1200
Seattle, WA 98164

EUROPEAN Headquarters

+44 (0) 20 8037.2308
1st Floor Saffron House
6-10 Kirby Street
London EC1N 8TS
United Kingdom

Contact Us

info@pitchbook.com
Request Research
Profile Request
Deal Submission

Follow us







© 2021 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.

Terms of Use
Privacy Policy
California Consumer: Do Not Sell My Info



